LAVA Therapeutics N.V. (LVTX)
0.97
-0.01 (-1.02%)
At close: Jan 15, 2025, 3:57 PM
0.96
-1.03%
After-hours Jan 15, 2025, 05:20 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -41.70M | -31.66M | -51.23M | -20.44M | -10.99M |
| Depreciation & Amortization | 1.28M | 781.00K | 632.61K | 606.37K | 293.86K |
| Stock-Based Compensation | 5.04M | 4.11M | 4.43M | 683.09K | 217.84K |
| Other Working Capital | -4.75M | 32.70M | 10.45M | 7.19M | 882.72K |
| Other Non-Cash Items | -488.00K | -3.06M | 1.14M | 690.84K | -192.08K |
| Deferred Income Tax | -279.00K | -249.00K | -177.99K | -52.79K | n/a |
| Change in Working Capital | -2.83M | 34.11M | 12.29M | 5.71M | 704.59K |
| Operating Cash Flow | -38.97M | 4.04M | -32.48M | -12.77M | -9.77M |
| Capital Expenditures | -730.00K | -587.00K | -866.15K | -659.16K | -864.57K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -90.08M | -70.88M | -51.35M | n/a | -34.04K |
| Sales Maturities Of Investments | 73.18M | 80.81M | 2.85M | n/a | n/a |
| Other Investing Acitivies | n/a | 9.28M | -42.61M | n/a | -29.50K |
| Investing Cash Flow | -17.64M | 9.35M | -49.37M | -659.16K | -898.61K |
| Debt Repayment | -571.00K | 268.00K | 340.00K | 1.79M | 1.18M |
| Common Stock Repurchased | n/a | n/a | n/a | -6.15M | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | 15.00K | 56.63M | 17.18M | n/a |
| Financial Cash Flow | -571.00K | 283.00K | 171.37M | 24.20M | 1.33M |
| Net Cash Flow | -56.10M | 9.46M | 85.09M | 9.56M | -9.83M |
| Free Cash Flow | -39.70M | 3.46M | -33.34M | -13.42M | -10.64M |